Epiregulin induces human SK-N-BE cell differentiation through ERK1/2 signaling pathway

Growth Factors

Volumn 31, Issue 3, 2013, Pages 90-97

  Rizzi, Manuela ^a   Pittarella, Pamela ^a   Sabbatini, Maurizio ^a   Renò, Filippo ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Differentiation; ERK1 2; MMPs; Neuroblastoma; SK N BE cell line

Indexed keywords

EPIREGULIN; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEURONS;

EID: 84878811812     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977194.2013.795958     Document Type: Article

References (27)

1. Bacus SS, Chin D, Yarden Y, Zelnick CR, Stern DF. 1996. Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors. Am J Path 148:549-558. (Pubitemid 26056739)
2. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS. 1978. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 36:3751-3757. (Pubitemid 9045201)
3. Brignole C, Pagnan G, Marimpietri D, Cosimo E, Allen TM, Ponzoni M, Pastorino F. 2003. Targeted delivery system for antisense oligonucleotides: A novel experimental strategy for neuroblastoma treatment. Cancer Lett 197:231-235. (Pubitemid 36860016)
4. Campostrini N, Pascali J, Hamdan M, Astner H, Marimpietri D, Pastorino F, Ponzoni M, Righetti PG. 2004. Proteomic analysis of an orthotopic neuroblastoma xenograft animal model. J Chromatogr B Analyt Technol Biomed Life Sci 808:279-286. (Pubitemid 38952923)
5. Chambaut-Guérin AM, Hérigault S, Rouet-Benzineb P, Rouher C, Lafuma C. 2000. Induction of matrix metalloproteinase MMP-9 (92 kDa gelatinase) by retinoic acid in human neuroblastoma SKNBE cells: Relevance to neuronal differentiation. J Neurochem 74: 508-517. (Pubitemid 30053722)
6. Chen X, Levkowitz G, Tzahar E, Karunagaran D, Lavi S, Ben-Baruch N, Leitner O, et al. 1996. An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB-4. J Biol Chem 271:7620-7629. (Pubitemid 26107041)
7. Chiu B, Mirkin B, Madonna MB. 2006. Mitogenic and apoptotic actions of epidermal growth factor on neuroblastoma cells are concentrationdependent. J Surg Res 135:209-212. (Pubitemid 44414891)
8. Chiu B, Mirkin B, Madonna MB. 2007a. Novel action of epidermal growth factor on caspase 3 and its potential as a chemotherapeutic adjunct for neuroblastoma. J Pediatr Surg 42:1389-1395. (Pubitemid 47238328)
9. Chiu B, Mirkin B, Madonna MB. 2007b. Epidermal growth factor can induce apoptosis in neuroblastoma. J Pediatr Surg 42:482-488.
10. Ciana P, Ghisletti S, Mussi P, Eberini I, Vegeto E, Maggi A. 2003. Estrogen receptor alpha, a molecular switch converting transforming growth factor-alpha-mediated proliferation into differentiation in neuroblastoma cells. J Biol Chem 278:31737-31744. (Pubitemid 37048354)
11. Harris RC, Chung E, Coffey RJ. 2003. EGF receptor ligands. Exp Cell Res 284:2-13. (Pubitemid 36331964)
12. Ho R, Minturn JE, Hishiki T, Zhao H, Wang Q, Cnaan A, Maris J, et al. 2005. Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor. Cancer Res 65:9868-9875. (Pubitemid 41541466)
13. Holbro T, Hynes NE. 2004. ErbB receptors: Directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol 44:195-217. (Pubitemid 38263839)
14. Hynes NE, Horsch K, Olayioye MA, Badache A. 2001. The ErbB receptor tyrosine family as signal integrators. Endocr Relat Cancer 8: 151-159. (Pubitemid 32947637)
15. Jones FE, Jerry DJ, Guarino BC, Andrews GC, Stern DF. 1996. Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli. Cell Growth Differ 7: 1031-1038. (Pubitemid 26360714)
16. Komurasaki T, Toyoda H, Uchida D, Morimoto S. 2006. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4. Oncogene 15:2841-2848.
17. Makowski GS, Ramsby ML. 1996. Calibrating gelatin zymograms with human gelatinase standards. Anal Biochem 236:353-356. (Pubitemid 26136117)
18. Martinez R, Eller C, Viana NB, Gomes FCA. 2011. Thyroid hormone induces cerebellar neuronal migration and Bergmann glia differentiation through epidermal growth factor/mitogen-activated protein kinase pathway. Eur J Neurosci 33:26-35.
19. Morita S, Shirakata Y, Shiraishi A, Kadota K, Hashimoto K, Higashiyama S, Ohashi Y. 2007. Human corneal epithelial cell proliferation by epiregulin and its cross-induction by other EGF family members. Mol Vis 13:2119-2128. (Pubitemid 350176249)
20. Pastorino F, Loi M, Sapra P, Becherini T, Cilli M, Emionite L, Ribatti D, et al. 2010. Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor. Clin Cancer Res 16:4809-4821.
21. Raffaghello L, Zuccari G, Carosio R, Orienti I, Montaldo PG. 2006. In vitro and in vivo antitumor activity of the novel derivatized polyvinyl alcohol-based polymer P10(4). Clin Cancer Res 12: 3485-3493.
22. Richards KN, Zweidler-McKay PA, Van Roy N, Speleman F, Treviño J, Zage PE, Hughes DPM. 2010. Signaling of ERBB receptor tyrosine kinases promote neuroblastoma growth in vitro and in vivo. Cancer 116:3233-3243.
23. Riese II DJ, Komurasaki T, Plowman GD, Stern DF. 1998. Activation of ErbB4 by the bifunctional epidermal growth factor family hormone Epiregulin is regulated by ErbB2. J Biol Chem 273: 11288-11294. (Pubitemid 28204982)
24. Shelly M, Pinkas-Kramarski R, Guarino BC, Waterman H, Wang LM, Lyass L, Alimandi M, et al. 1998. Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes. J Biol Chem 273:10496-10505. (Pubitemid 28227660)
25. Shirakata Y, Komurasaki T, Toyoda H, Hanakawa Y, Yamasaki K, Tokumaru S, Sayama K, et al. 2000. Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes. J Biol Chem 275: 5748-5753. (Pubitemid 30115217)
26. Wong RWC, Guillaud L. 2004. The role of epidermal growth factor and its receptors in mammalian CNS. Cytokine Growth Factor Rev 15: 147-156. (Pubitemid 38521250)
27. Yarden Y, Sliwkowski MX. 2001. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127-137. (Pubitemid 33674041)